ORD co-sponsored Scientific Conferences


Co-funding Institute(s):  National Cancer Institute (NCI)


Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation , June 2009
Bethesda, MD, United States
Contact for additional information: Dr. Michael R. Bishop, NCI 301-435-2764


Description
The goals of this conference are to (1) establish guidelines for the monitoring of relapse following allogeneic HSCT, (2) identify high-risk populations (develop relapse index), (3) develop disease-specific monitoring techniques, (4) create recommendations for treatment of relapse following allogeneic HSCT, and (5) establish guidelines for the conduct of clinical trials for the treatment of relapse following allogeneic HSCT.



Note: If you need help accessing information in different file formats such as PDF, MP3, see Viewers, Players, and Plug-ins.